Latest market price
30.70
+0.04+0.13%
TA
Loading chart...
Snapshot
| Index | — | P/E | 7.84 | EPS (ttm) | 3.91 | Insider Own | — | Shs Outstand | 13.24M | Perf Week | 3.65% |
| Market Cap | 405.87M | Forward P/E | — | EPS next Y | -2.01 | Insider Trans | 0.18% | Shs Float | 12.23M | Perf Month | -9.85% |
| Enterprise Value | 1.03B | PEG | — | EPS next Q | -0.49 | Short Float | 7.62% | Perf Quarter | -12.70% | ||
| Income | 57.00M | P/S | 2.59 | EPS this Y | — | Short Ratio | 9.20 | Perf Half Y | -12.30% | ||
| Sales | 157.00M | P/B | 0.59 | EPS next Y | -167.09% | ROA | 4.22% | Short Interest | 931.98K | Perf YTD | — |
| Book/sh | 51.67 | P/C | 36.90 | EPS next 5Y | — | ROE | 10.77% | 52W High | 38.65 -20.57% | Perf Year | — |
| Cash/sh | 0.83 | P/FCF | — | EPS past 3/5Y | — | ROIC | 24.98% | 52W Low | 28.09 9.29% | Perf 3Y | — |
| Dividend Est. | 0.64 (2.08%) | EV/EBITDA | 6.54 | Sales past 3/5Y | 5.53% 11.36% | Gross Margin | 0.39% | Volatility | 3.83% 3.10% | Perf 5Y | — |
| Dividend TTM | 2.30 (7.49%) | EV/Sales | 6.58 | EPS Y/Y TTM | 177.30% | Oper. Margin | 25.50% | ATR (14) | 0.98 | Perf 10Y | — |
| Dividend Ex-Date | Nov 20, 2026 | Quick Ratio | 20.79 | Sales Y/Y TTM | 6.08% | Profit Margin | 36.96% | RSI (14) | 42.32 | Recom | 2.60 |
| Dividend Gr. 3/5Y | -7.72% -3.77% | Current Ratio | 20.79 | EPS Q/Q | 9660.00% | SMA20 | -1.53% | Beta | 0.38 | Target Price | 41.00 |
| Payout | 84.16% | Debt/Eq | 0.93 | Sales Q/Q | -2.44% | SMA50 | -10.20% | Rel Volume | 1.78 | Prev Close | 30.66 |
| Employees | 30 | LT Debt/Eq | 0.93 | Earnings | Nov 04 | SMA200 | -13.09% | Avg Volume | 136.16K | Price | 30.70 |
| IPO Date | Jun 29, 2016 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2134.04% -1.55% | Net Debt/EBITDA | 3.97 | Volume | 242,267 | Change | 0.13% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-21-26 | Initiated | Cantor Fitzgerald | Overweight | $43 |
| Jul-01-26 | Reiterated | Industrial Alliance Securities | $40 → $43 | |
| May-18-26 | Reiterated | BMO Capital | Market Perform | $39 |
| May-07-26 | Reiterated | Industrial Alliance Securities | $42 → $40 | |
| May-07-26 | Downgrade | Compass Point | Buy → Neutral | $38 |
| Oct-13-25 | Upgrade | JMP Securities | Market Perform → Market Outperform |
Latest News· Times ET
Oct-28-26
Oct-23-26
Oct-23-2611:16PM
Oct-19-26
Oct-19-2604:10PM
Oct-16-26
Oct-16-2602:45AM
Oct-10-26
Oct-09-26
Oct-07-26
Oct-07-2604:05PM
Sep-21-26
02:45AM
Brokerages Set Global Medical REIT Inc. (NYSE:XRN) PT at $39.60defenseworld.net
Sep-12-26
Aug-30-26
Aug-26-26
Aug-26-2604:05PM
Aug-25-26
Aug-25-2601:29PM
Aug-18-26
Aug-18-2604:05PM
Aug-17-26
Company
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 157 | 161 | 138 | 141 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 156 | 151 | 29 | 28 | — | — | — | — | — | |
| Gross Profit | 0 | 10 | 109 | 113 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 29 | 20 | 21 | 17 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -68 | -59 | 55 | 58 | — | — | — | — | — | |
| Operating Income | 39 | 49 | 33 | 38 | — | — | — | — | — | |
| Interest Expense | 36 | 45 | 29 | 31 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 59 | -12 | 3 | 15 | — | — | — | — | — | |
| Net Income Before Taxes | 63 | -7 | 7 | 22 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 57 | -6 | 7 | 21 | — | — | — | — | — | |
| Net Income From Continuing Operations | 63 | -7 | 7 | 22 | — | — | — | — | — | |
| Net Income | 57 | -6 | 7 | 21 | — | — | — | — | — | |
| EPS (Recurring) | 3.91 | -0.91 | 0.31 | 5.75 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.91 | -0.91 | 0.31 | 5.75 | — | — | — | — | — | |
| EPS (Diluted) | 3.91 | -0.91 | 0.31 | 5.75 | — | — | — | — | — | |
| EBITDA | 158 | 97 | 91 | 112 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 7.85 | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.54 | — | — | — | — | — | — | — | — | |
| Gross Margin | 0.00 | 6.21 | 78.99 | 80.14 | — | — | — | — | — | |
| Operating Margin | 24.84 | 30.43 | 23.91 | 26.95 | — | — | — | — | — | |
| Net Margin | 36.31 | -3.73 | 5.07 | 14.89 | — | — | — | — | — | |
| Shares Outstanding | 13 | 13 | 3 | 3 | — | — | — | — | — | |
| Market Capitalization | 399 | — | — | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Whitlock Matthew Fitzsimmons | Chief Investment Officer | Aug 17 '26 | Buy | 36.38 | 500 | 18,190 | 2,000 | Aug 17 |
| Whitlock Matthew Fitzsimmons | Chief Investment Officer | Aug 14 '26 | Buy | 37.21 | 500 | 18,605 | 1,500 | Aug 17 |
| Roseth Aaron Robert | COO | Aug 12 '26 | Buy | 36.73 | 13,500 | 495,855 | 13,500 | Aug 13 |
| Fitzgerald Charles | Director | Aug 11 '26 | Buy | 35.78 | 14,000 | 500,920 | 138,893 | Aug 13 |
| Decker Mark Okey Jr | CEO and President | Aug 11 '26 | Buy | 35.93 | 7,425 | 266,750 | 75,199 | Aug 13 |
| Decker Mark Okey Jr | CEO and President | Aug 10 '26 | Buy | 35.88 | 8,000 | 287,040 | 67,774 | Aug 12 |
| Fitzgerald Charles | Director | Aug 10 '26 | Buy | 35.94 | 27,600 | 991,944 | 124,893 | Aug 12 |
| Cypher Matthew | Director | May 14 '26 | Buy | 35.12 | 1,420 | 49,874 | 1,690 | May 15 |
| Wittman Lori | Director | May 12 '26 | Buy | 33.85 | 2,940 | 99,515 | 2,940 | May 13 |
| Marston Ronald | Director | May 12 '26 | Buy | 34.07 | 1,500 | 51,111 | 3,066 | May 13 |
| Barber Jamie Allen | General Counsel and Secretary | May 12 '26 | Buy | 33.50 | 1,481 | 49,614 | 1,481 | May 13 |
| Holley Danica | COO | May 12 '26 | Buy | 33.99 | 1,490 | 50,645 | 1,590 | May 12 |
| Decker Mark Okey Jr | CEO and President | May 12 '26 | Buy | 33.94 | 5,000 | 169,700 | 59,774 | May 12 |
| KIERNAN ROBERT J | CFO and Treasurer | May 11 '26 | Buy | 33.49 | 3,000 | 100,470 | 6,000 | May 12 |
| Cole Henry | Director | May 11 '26 | Buy | 34.30 | 583 | 19,998 | 2,129 | May 11 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.